SFX by Ex Libris Inc.

Title:	Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease
Source:	Nature Genetics [1061-4036] Lee, James yr:2017

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Seshadri, S. "Genome-wide analysis of genetic loci associated with Alzheimer disease." JAMA 303.18 (2010): 1832-1840.
description	2.	Hollingworth, P. "Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease." Nature Genetics 43.5 (2011): 429-435.
description	3.	Shulman, Joshua M. "Evidence for a common pathway linking neurodegenerative diseases." Nature Genetics 41.12 (2009): 1261-1262.
description	4.	Harold, D. "Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease." Nature Genetics 41.10 (2009): 1156-1156.
description	5.	Tanzi, L. "Genome-wide association studies in Alzheimer's disease." Human Molecular Genetics 18.R2 (2009): 2113-45.
description	6.	Naj, Adam C. "Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease." Nature Genetics 43.5 (2011): 436-41.
description	7.	Smith, P. "Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease." Nature Genetics 45.12 (2013): 1452-1458.
description	8.	Gu, T-L D. "Identification of activated Tnk1 kinase in Hodgkin's lymphoma." Leukemia 24.4 (2010): 861-865.
description	9.	Carrasquillo, M. "Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease." Nature genetics 41.2 (2009): 192-198.
description	10.	Meinert, Curtis L. "Chronic disease long-term drug prevention trials: lessons from the Alzheimer's disease anti-inflammatory prevention trial (ADAPT)." Alzheimer's & dementia 4.1, Suppl. 1 (2008): 7-.
description	11.	Bertram, R E E. "New frontiers in Alzheimer's disease genetics." Neuron 32.2 (2001): 181-4.
description	12.	Corder, M A A. "Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families." Science 261.5123 (1993): 921-3.
description	13.	Blennow, K. "Alzheimer's disease." The lancet 368.9533 (2006): 387-403.
description	14.	Radde, R. "The value of incomplete mouse models of Alzheimer's disease." European journal of nuclear medicine and molecular imaging 35.1 (2008): 70-4.
description	15.	Vanderhaeghen, P. "The ephrins and Eph receptors in neural development." Annual Review of Neuroscience 21.1 (1998): 309-45.
description	16.	Buxbaum, Joseph D, Joseph D. "Alzheimer genetics, part I." Nature genetics 27.3 (2001): 245-245.
description	17.	Taylor, Kenneth H P. "Toxic Proteins in Neurodegenerative Disease." Science 296.5575 (2002): 1991-5.
description	18.	Farrer, Matthew James J. "Genetics of Parkinson disease: paradigm shifts and future prospects." Nature reviews. Genetics 7.4 (2006): 306-18.
description	19.	LaFerla, Frank M M. "Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease." Nature reviews. Neuroscience 3.11 (2002): 862-72.
description	20.	Lin Lee, Y C. "Apolipoprotein E gene mapping and expression: localization of the structural gene to human chromosome 19 and expression of ApoE mRNA in lipoprotein- and non-lipoprotein-producing tissues." Biochemistry 24.14 (1985): 3751-6.